Brain+ A/S specializes in developing digital therapeutic solutions for... Brain+ A/S specializes in developing digital therapeutic solutions for individuals coping with Alzheimer's and various types of dementia. The company's portfolio includes Cognitive Stimulation Therapy (CST), which targets the primary symptoms of dementia, and Computerized Cognitive Training, a method designed for patients experiencing mild cognitive impairment. Additionally, Brain+ offers "Starry Night," a memory assessment tool crucial for the early detection and continuous monitoring of Alzheimer's disease. The firm also provides an intuitive interface that enables clinicians to effectively track and oversee patient treatment progress. Established in 2012, this Copenhagen, Denmark-based company was formerly a subsidiary of Brain+ Holding ApS.
